Combatting Malaria with CAMOSUNATE CHILDREN (1-6 YEARS)
CAMOSUNATE CHILDREN (1-6YRS) is a targeted medication formulated for young children aged 1 to 6 years, specifically addressing chloroquine-resistant malaria, malarial infections, and various other related conditions.
Active Ingredients
Containing a powerful blend of active ingredients—Amodiaquine and Artesunate—this medication offers a potent combination to effectively combat malaria and its resistant strains in young children.
Health Benefits
Treats chloroquine-resistant malaria and malarial infections
Specifically designed for children aged 1 to 6 years
Offers relief and treatment for various malarial conditions
Precautions and Side Effects
It’s crucial to consider potential side effects such as nausea, vomiting, diarrhea, and abdominal pain. Consult a healthcare professional before administering this medication to young children and be vigilant for any adverse reactions.
